A crescent-shaped, concave, fibrocartilaginous meniscus tissue exists between the knee joint's tibial plateau and femoral condyle [1]. This tissue stabilizes the knee, absorbs shock, and distributes axial loads [2]. Meniscus tears have increased to approximately 60 per 100,000 population mostly among the people who are involved in sports activities. The meniscus tear can be diagnosed by using a simple radiologic technique, Magnetic Resonance Imaging (MRI). If those tears are left without treatment, meniscus injury leads to knee pain and osteoarthritis [3]. Unfortunately, the meniscus has a poor self-healing capacity due to its limited blood supply. Therefore, the tissue engineering approach with the combination of cells, scaffolds, and growth factors is becoming promising for meniscus repair. This technique deals not only with the regeneration using engineered constructs but also cell-matrix interactions. Meniscus scaffolds should be three-dimensional biomimetic porous constructs that allow cell migration and proliferation without cytotoxicity. The engineered scaffolds should trigger fibrocartilage-like cell growth for constructing meniscus tissue [4].
Mesenchymal stem cells (MSCs) are attractive cell sources in tissue engineering applications. They can be easily isolated from many sources such as; adipose tissue, bone marrow, synovium, umbilical cord, amniotic fluid, periosteum, etc. For the last two decades, the potential of MSCs isolated from different sources was investigated in many studies, and their advantages/disadvantages were determined [5]. These cells can be defined easily by using flow cytometry analysis with the positive expression of CD73, CD90, and CD105, whereas negative to the hematopoietic and endothelial markers of CD34, CD45, and HLA-DR [6]. They also have anti-inflammatory potential with the ability of self-renewal and differentiation [7]. In our previous studies, meniscus scaffolds were successfully produced, and in-vitro biocompatibility studies were conducted by using these multipotent stem cells. MSC-seeded meniscus scaffolds have been found to trigger the deposition of type I and especially type II collagen [8, 9].
Meniscus is mostly composed of type I and II collagen (the wet weight is about 22%), glycosaminoglycans (GAGs) such as chondroitin sulfate (the wet weight is about 0.8%), and water (72%). Negatively charged proteoglycans attract the counter ions and water to the meniscus, and the tissue becomes viscoelastic and absorbs compressive loads. Whereas, the circumferentially arranged collagen bundles provide tensile strength. This anisotropic arrangement of collagen microstructure is important for the meniscus biomechanics [2]. The tensile modulus of menisci was previously described in the literature, which was given in the range of 40–300 MPa circumferentially, and 10–30 MPa radially [10].
Chitosan is a linear polysaccharide produced by the deacetylation of chitin which is mainly obtained from the shells of shrimps and crabs. Chitosan is a widely used polymer in tissue engineering applications due to its structural similarity with GAGs and anti-bacterial properties [11]. On the other hand, collagen is the most abundant protein in the human body which is categorized into almost 28 subtypes. Types I, II, and III collagen are widely distributed in tissues including bone, cartilage, skin, and other connective tissues. Since collagen can provide better biomimicry properties, researchers have preferred to use collagen in tissue engineering applications [12].
Our research group previously prepared a collagen-chitosan hydrogel composite scaffold consisting of 3D printed PLA strut and cellulose nanofibers [9] as well as a loofah-reinforced and PHBV nanofiber incorporated chitosan hydrogel composite scaffold for meniscus regeneration [8]. In both studies, micro- and nano-sized topographical features favored MSCs adhesion and spreading. Especially, loofah together with PHBV nanofibers were shown to be a promising reinforcement to regenerate meniscus tissue. Loofah is a fibrous plant named Luffa cylindrica and it was first introduced as a potential porous scaffolding material for bone and cartilage tissue engineering by Cecen, B. [13] and Baysan, G. [14]. Besides, PHBV which is a biodegradable microbial polyester, is another preferred polymer in tissue engineering applications due to its high spinnability in nanofibrous form and biocompatibility [15].
In light of our previous studies, in the present study, novel collagen-chitosan hydrogel composite scaffolds crosslinked with three different concentrations of genipin (0.1, 0.3, and 0.5%) were produced comprising PHBV nanofiber integrated loofah mats for meniscus tissue engineering applications. Scanning electron microscope (SEM) and Fourier-transformed infrared spectrometer (FTIR) were used for the morphological and chemical characterizations of the scaffolds, respectively. The swelling ratio and water content values of the scaffolds were calculated using a swelling test. The scaffolds’ viscoelastic and mechanical properties were determined by dynamic mechanical analysis and compression test, respectively. Furthermore, in vitro biocompatibility analysis was conducted by using rabbit bone marrow-derived mesenchymal stem cells (rMSCs). Cytotoxicity and cell proliferation assessments of the scaffolds were performed using LDH and WST-1 assay kits, respectively. SEM and fluorescence microscopy were used to observe cell attachment and spreading. Besides, histological stainings were examined to observe the cells on the cross-sections of the scaffolds and immunohistochemical analyses were evaluated in terms of collagen type I and II depositions. In addition, the biocompatibility of the scaffolds was further investigated by in vivo analysis performed on 24 adult male New Zealand rabbits in three groups (n = 8) (empty defect, cell-free and cell-laden implanted scaffolds) following a meniscus regeneration model. Finally, post-implantation microcomputer tomography (Micro-CT) imaging, in vivo biomechanical tests, histological and immunohistochemical analyses were evaluated for meniscus regeneration success of the designed scaffolds implanted with or without rMSCs.